Telemus Capital’s Core Laboratories CLB Stock Holding History

Telemus Capital’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-43,785	Closed	-$3.02M	–	380
2019 Q1	$3.02M	Buy	43,785 +28,086	+179%	+$1.88M	0.23%	95
2018 Q4	$937K	Sell	15,699 -15,317	-49%	-$1.32M	0.08%	192
2018 Q3	$3.59M	Sell	31,016 -71	-0.2%	-$8.01K	0.27%	81
2018 Q2	$3.92M	Buy	31,087 +142	+0.5%	+$17.3K	0.3%	71
2018 Q1	$3.35M	Buy	30,945 +5,706	+23%	+$631K	0.27%	78
2017 Q4	$2.77M	Sell	25,239 -1,500	-6%	-$150K	0.21%	93
2017 Q3	$2.64M	Sell	26,739 -752	-3%	-$72.9K	0.3%	68
2017 Q2	$2.78M	Buy	27,491 +889	+3%	+$95.8K	0.28%	71
2017 Q1	$3.07M	Sell	26,602 -1,808	-6%	-$210K	0.32%	64
2016 Q4	$3.41M	Buy	28,410 +5,893	+26%	+$652K	0.46%	55
2016 Q3	$2.53M	Buy	22,517 +7,538	+50%	+$868K	0.28%	72
2016 Q2	$1.86M	Buy	14,979 +278	+2%	+$33.6K	0.23%	93
2016 Q1	$1.65M	Buy	14,701 +3,493	+31%	+$363K	0.27%	87
2015 Q4	$1.22M	Buy	11,208 +1,837	+20%	+$210K	0.33%	67
2015 Q3	$935K	Buy	9,371 +820	+10%	+$89.2K	0.24%	66
2015 Q2	$975K	Buy	8,551 +200	+2%	+$24.3K	0.25%	65
2015 Q1	$873K	Buy	+8,351	New	+$890K	0.21%	68

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Telemus Capital's CLB Position: Q2 2019 in Review

Telemus Capital sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 43,785 shares — an estimated $3.02M sold.

Telemus Capital first reported a position in CLB in Q1 2015 and held it in 17 quarters. The position peaked at $3.92M in Q2 2018. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

Telemus Capital reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
Telemus Capital sold 43,785 Core Laboratories shares in Q2 2019, an estimated $3.02M.
Telemus Capital first reported a position in Core Laboratories in Q1 2015 and held it in 17 quarters.
Telemus Capital's Core Laboratories position peaked at $3.92M in Q2 2018.
304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on Telemus Capital's 13F filing for Q2 2019, filed 9 Aug 2019.